S00–T88
Injury, Poisoning and Certain Other Consequences of External Causes
Fractures, burns, poisoning, traumatic injuries
T44.3X3A
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter
Billable
T44.3X3D
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter
Billable
T44.3X3S
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela
Billable
T44.3X4
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined
Non-billable
T44.3X4A
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
Billable
T44.3X4D
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter
Billable
T44.3X4S
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela
Billable
T44.3X5
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
Non-billable
T44.3X5A
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
Billable
T44.3X5D
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
Billable
T44.3X5S
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
Billable
T44.3X6
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
Non-billable
T44.3X6A
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
Billable
T44.3X6D
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
Billable
T44.3X6S
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
Billable
T44.4
Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists
Non-billable
T44.4X
Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists
Non-billable
T44.4X1
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional)
Non-billable
T44.4X1A
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
Billable
T44.4X1D
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
Billable
T44.4X1S
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela
Billable
T44.4X2
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm
Non-billable
T44.4X2A
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
Billable
T44.4X2D
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter
Billable
T44.4X2S
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela
Billable
T44.4X3
Poisoning by predominantly alpha-adrenoreceptor agonists, assault
Non-billable
T44.4X3A
Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
Billable
T44.4X3D
Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter
Billable
T44.4X3S
Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela
Billable
T44.4X4
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined
Non-billable
T44.4X4A
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
Billable
T44.4X4D
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter
Billable
T44.4X4S
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela
Billable
T44.4X5
Adverse effect of predominantly alpha-adrenoreceptor agonists
Non-billable
T44.4X5A
Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
Billable
T44.4X5D
Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
Billable
T44.4X5S
Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
Billable
T44.4X6
Underdosing of predominantly alpha-adrenoreceptor agonists
Non-billable
T44.4X6A
Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter
Billable
T44.4X6D
Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter
Billable
T44.4X6S
Underdosing of predominantly alpha-adrenoreceptor agonists, sequela
Billable
T44.5
Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
Non-billable
T44.5X
Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
Non-billable
T44.5X1
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)
Non-billable
T44.5X1A
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter
Billable
T44.5X1D
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
Billable
T44.5X1S
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela
Billable
T44.5X2
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm
Non-billable
T44.5X2A
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter
Billable
T44.5X2D
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter
Billable
Search all 98,186 codes instantly
Search ICDwise →